Krystal Biotech EPS Diluted (TTM) Analysis

Krystal Biotech Inc (KRYS)

154.52 -4.22 (-2.66%) USD | NASDAQ | May 10, 16:00

154.52 0.00 (0.00%) After-Hours: 20:00

EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	1.88
December 31, 2023	0.09
September 30, 2023	-1.47
June 30, 2023	-5.43
March 31, 2023	-5.28
December 31, 2022	-5.51
September 30, 2022	-5.21
June 30, 2022	-4.74
March 31, 2022	-4.38
December 31, 2021	-3.13
September 30, 2021	-2.71
June 30, 2021	-2.50
March 31, 2021	-2.13
December 31, 2020	-1.70

Date	Value
September 30, 2020	-1.48
June 30, 2020	-1.24
March 31, 2020	-1.24
December 31, 2019	-1.22
September 30, 2019	-1.19
June 30, 2019	-1.20
March 31, 2019	-1.05
December 31, 2018	-0.97
September 30, 2018	-0.8251
June 30, 2018	-1.825
March 31, 2018	-1.693
December 31, 2017	-1.598
September 30, 2017	-1.610
June 30, 2017	-0.4249

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (TTM) Range, Past 5 Years

-5.51

Minimum

Dec 2022

1.88

Maximum

Mar 2024

-2.490

Average

-1.915

Median

EPS Diluted (TTM) Benchmarks